Sign up to save your podcasts
Or
Share Align Summit: Cambridge based Quiver Bioscience is developing ASOs for CNS conditions, including having programs in the red hot Nav1.7/1.8 pain space
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Align Summit: Cambridge based Quiver Bioscience is developing ASOs for CNS conditions, including having programs in the red hot Nav1.7/1.8 pain space
Co-Founder & CEO Graham Dempsey describes the different between Nav1.7 and 1.8, and why he thinks having an ASO approach will succeed in 1.7 where small molecules have not. Plus, an epilepsy program, and what it is like being an earlier stage company today.
View all episodes
By BiotechTV
4.3
77 ratings
Co-Founder & CEO Graham Dempsey describes the different between Nav1.7 and 1.8, and why he thinks having an ASO approach will succeed in 1.7 where small molecules have not. Plus, an epilepsy program, and what it is like being an earlier stage company today.
More shows like BiotechTV - News
View all
WSJ What’s News
4,413 Listeners
The a16z Show
1,107 Listeners
The Meb Faber Show - Better Investing
948 Listeners
The Daily
113,475 Listeners
The Readout Loud
336 Listeners
The Intelligence from The Economist
2,569 Listeners
The Prof G Pod with Scott Galloway
5,659 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
10,233 Listeners
Business Of Biotech
87 Listeners
BioCentury This Week
35 Listeners
Biotech Hangout
21 Listeners
BG2Pod with Brad Gerstner and Bill Gurley
460 Listeners
Prof G Markets
1,476 Listeners
The BioCentury Show
12 Listeners
The Studio at Kendall Square
0 Listeners
Off-Target Effects with Matt Gline
4 Listeners
Biotech CEO Sisterhood
3 Listeners
BioVenture VoiCes with Chris Garabedian
6 Listeners